Yu ML - Search Results

1

The status of serum hepatitis B virus DNA in HBSAG-positive hepatocellular carcinoma.

Yu ML, Chuang WL, Chow TY, Chen SC, Lu SN, Lin ZY, Hsieh MY, Wang LY, Chang WY. Yu ML, et al. Kaohsiung J Med Sci. 1996 Aug;12(8):466-70. Kaohsiung J Med Sci. 1996. PMID: 8774115

2

Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma.

Jeng JE, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF. Jeng JE, et al. Among authors: yu ml. Tumour Biol. 2014 Apr;35(4):3689-98. doi: 10.1007/s13277-013-1488-2. Epub 2013 Dec 30. Tumour Biol. 2014. PMID: 24375326

3

Interactive effects between Lymphotoxin α +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma.

Tsai JF, Chen SC, Lin ZY, Dai CY, Huang JF, Yu ML, Chuang WL. Tsai JF, et al. Among authors: yu ml. Kaohsiung J Med Sci. 2017 Jul;33(7):334-338. doi: 10.1016/j.kjms.2017.04.010. Epub 2017 May 31. Kaohsiung J Med Sci. 2017. PMID: 28738973 Free article.

4

Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.

Tsai JF, Chen SC, Lin ZY, Dai CY, Huang JF, Yu ML, Chuang WL. Tsai JF, et al. Among authors: yu ml. Kaohsiung J Med Sci. 2017 Sep;33(9):453-457. doi: 10.1016/j.kjms.2017.04.009. Epub 2017 May 25. Kaohsiung J Med Sci. 2017. PMID: 28865603 Free article.

5

Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.

Tsai JF, Jeng JE, Chuang LY, You HL, Ho MS, Lai CS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY. Tsai JF, et al. Among authors: yu ml. Tumour Biol. 2003 Nov-Dec;24(6):291-8. doi: 10.1159/000076461. Tumour Biol. 2003. PMID: 15004489

6

Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.

Tsai JF, Jeng JE, Chuang LY, You HL, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY. Tsai JF, et al. Among authors: yu ml. Scand J Gastroenterol. 2005 Jan;40(1):68-75. doi: 10.1080/00365520410009311. Scand J Gastroenterol. 2005. PMID: 15841717

7

Treatment of chronic hepatitis C with interferon-alpha: a preliminary report.

Yu ML, Chuang WL, Chen SC, Lu SN, Wang JH, Lin ZY, Hsieh MY, Wang LY, Chang WY. Yu ML, et al. Kaohsiung J Med Sci. 1996 Oct;12(10):581-9. Kaohsiung J Med Sci. 1996. PMID: 8918079 Clinical Trial.

8

The genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection in southern Taiwan.

Yu ML, Chuang WL, Lu SN, Chen SC, Wang JH, Lin ZY, Hsieh MY, Wang LY, Chang WY. Yu ML, et al. Kaohsiung J Med Sci. 1996 Nov;12(11):605-12. Kaohsiung J Med Sci. 1996. PMID: 8953853

9

Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area.

Lu SN, Chen HC, Tang CM, Wu MH, Yu ML, Chuang WL, Lu CF, Chang WY, Chen CJ. Lu SN, et al. Among authors: yu ml. Pediatr Infect Dis J. 1998 Feb;17(2):142-5. doi: 10.1097/00006454-199802000-00012. Pediatr Infect Dis J. 1998. PMID: 9493811

10

A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan.

Wang JH, Lu SN, Wu JC, Huang JF, Yu ML, Chen SC, Chuang WL. Wang JH, et al. Among authors: yu ml. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):253-4. doi: 10.1016/s0035-9203(99)90012-3. Trans R Soc Trop Med Hyg. 1999. PMID: 10492752 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

796 results

Search Page

Filters